Search Login Register

Granisetron (Kytril) Summary

Description: A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.

Also Known As: Kytril; 1-Methyl-N-(endo-9-Methyl-9-Azabicyclo(3.3.1)non-3-yl)-1H-Indazole-3-Carboxamide; BRL-43694; BRL-43694A; Granisetron Hydrochloride Show All >>

Networked: 717 relevant articles (231 outcomes, 241 trials/studies) for this Drug

Key Diseases for which Granisetron is Relevant

  1. Vomiting : 125 outcomes 132 studies in 486 results
  2. Nausea : 77 outcomes 85 studies in 331 results
  3. Postoperative Nausea and Vomiting (PONV) : 77 outcomes 57 studies in 157 results
  4. Neoplasms (Cancer) : 18 outcomes 25 studies in 90 results
  5. Strabismus (Squint) : 8 outcomes 7 studies in 12 results
Show All >>

Drugs Related to Granisetron

  1. Dexamethasone (Maxidex)
  2. Ondansetron (Zofran)
  3. Droperidol
  4. Metoclopramide (Reglan)
  5. Cisplatin (Platino)
  6. Serotonin (5 Hydroxytryptamine)
  7. Antiemetics
  8. ramosetron (Nasea)
  9. tropisetron (Navoban)
  10. 5-HT3 Serotonin Receptors (5 HT3 Receptor)
Show All >>

Therapies Related to Granisetron

  1. Drug Therapy (Chemotherapy)
  2. Tonsillectomy
  3. Laparoscopic Cholecystectomy
  4. Gynecologic Surgical Procedures (Gynecologic Surgery)
  5. Adenoidectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.